# Michael Murphy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-murphy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,744 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 24 |
| i10-index | 34 |
| Last Known Institution | Magnolia Solar (United States) |
| OpenAlex ID | https://openalex.org/A5069878843 |
| ORCID iD | 0000-0003-0434-4567 |
| Works | 65 |

## Researcher papers

- [Mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/mapping-the-human-genetic-architecture-of-covid-19/)
- [Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19](https://scholariq.org/papers/inflammatory-profiles-across-the-spectrum-of-disease-reveal-a-distinct-role-for/)
- [Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study](https://scholariq.org/papers/development-and-validation-of-the-isaric-4c-deterioration-model-for-adults/)
- [The Preventability of Ventilator-associated Events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative](https://scholariq.org/papers/the-preventability-of-ventilator-associated-events-the-cdc-prevention-epicenters/)
- [Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK](https://scholariq.org/papers/risk-of-adverse-outcomes-in-patients-with-underlying-respiratory-conditions/)
- [Comparison of Trends in Sepsis Incidence and Coding Using Administrative Claims Versus Objective Clinical Data](https://scholariq.org/papers/comparison-of-trends-in-sepsis-incidence-and-coding-using-administrative-claims/)
- [Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial](https://scholariq.org/papers/chlorhexidine-versus-routine-bathing-to-prevent-multidrug-resistant-organisms/)
- [SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination](https://scholariq.org/papers/sars-cov-2-specific-nasal-iga-wanes-9-months-after-hospitalisation-with-covid-19/)
- [Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK](https://scholariq.org/papers/changes-in-in-hospital-mortality-in-the-first-wave-of-covid-19-a-multicentre/)
- [Descriptive Epidemiology and Attributable Morbidity of Ventilator-Associated Events](https://scholariq.org/papers/descriptive-epidemiology-and-attributable-morbidity-of-ventilator-associated/)
- [Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis](https://scholariq.org/papers/impact-of-proteinuria-and-kidney-function-decline-on-health-care-costs-and/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Nosocomial Infections in ICU](https://scholariq.org/topics/nosocomial-infections-in-icu/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Magnolia Solar (United States)](https://scholariq.org/institutions/magnolia-solar-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.